BACKGROUND: Hepatic encephalopathy is a syndrome whose physiopathology is poorly understood; therefore, current diagnostic tests are imperfect and modern therapy is nonspecific. Particularly, it has been suggested that inflammation plays an important role in the pathogenesis of portal hypertensive encephalopathy in the rat. AIM: We have studied an experimental model of portal hypertension based on a triple partial portal vein ligation in the rat to verify this hypothesis. METHODS: One month after portal hypertension we assayed in the splanchnic area (liver, small bowel and mesenteric lymph nodes) and in the central nervous system (hippocampus and cerebellum) fractalkine (CX3CL1) and stromal cell-derived factor alpha (SDF1-α) as well as their respective receptors (CX3CR1 and CXCR4) because of their key role in inflammatory processes. RESULTS: The significant increase of fractalkine in mesenteric lymph nodes (P<0.05) and its receptor (CX3CR1) in the small bowel (P<0.05) and hippocampus (P<0.01), associated with the increased expression of SDF1-α in the hippocampus (P<0.01) and the cerebellum (P<0.01) suggest that prehepatic portal hypertension in the rat induces important alterations in the expression of chemokines in the gut-brain axis. CONCLUSION: The present study revealed that portal hypertension is associated with splanchnic-brain inflammatory alterations mediated by chemokines.
BACKGROUND: Hepatic encephalopathy is a syndrome whose physiopathology is poorly understood; therefore, current diagnostic tests are imperfect and modern therapy is nonspecific. Particularly, it has been suggested that inflammation plays an important role in the pathogenesis of portal hypertensiveencephalopathy in the rat. AIM: We have studied an experimental model of portal hypertension based on a triple partial portal vein ligation in the rat to verify this hypothesis. METHODS: One month after portal hypertension we assayed in the splanchnic area (liver, small bowel and mesenteric lymph nodes) and in the central nervous system (hippocampus and cerebellum) fractalkine (CX3CL1) and stromal cell-derived factor alpha (SDF1-α) as well as their respective receptors (CX3CR1 and CXCR4) because of their key role in inflammatory processes. RESULTS: The significant increase of fractalkine in mesenteric lymph nodes (P<0.05) and its receptor (CX3CR1) in the small bowel (P<0.05) and hippocampus (P<0.01), associated with the increased expression of SDF1-α in the hippocampus (P<0.01) and the cerebellum (P<0.01) suggest that prehepatic portal hypertension in the rat induces important alterations in the expression of chemokines in the gut-brain axis. CONCLUSION: The present study revealed that portal hypertension is associated with splanchnic-brain inflammatory alterations mediated by chemokines.
Authors: Kenneth J Simpson; Neil C Henderson; Cynthia L Bone-Larson; Nicholas W Lukacs; Cory M Hogaboam; Steven L Kunkel Journal: Clin Sci (Lond) Date: 2003-01 Impact factor: 6.124
Authors: Silvia Lores-Arnaiz; Juan Carlos Perazzo; Juan Pablo Prestifilippo; Néstor Lago; Gabriela D'Amico; Analía Czerniczyniec; Juanita Bustamante; Alberto Boveris; Abraham Lemberg Journal: Neurochem Int Date: 2005-10 Impact factor: 3.921
Authors: Marta Méndez; Magdalena Méndez-López; Laudino Lopez; María A Aller; Jaime Arias; Jorge L Arias Journal: Brain Res Date: 2008-07-19 Impact factor: 3.252
Authors: José Joaquín Merino; María Eugenia Cabaña-Muñoz; Adolfo Toledano Gasca; Alba Garcimartín; Juana Benedí; Fabio Camacho-Alonso; José María Parmigiani-Izquierdo Journal: J Clin Med Date: 2019-09-02 Impact factor: 4.241